Artelo Biosciences ARTL
NASDAQ ARTL
$3.68 -0.15 (-3.92%)
At close: Oct 2, 2026 · 4:00 PM EDT

Artelo Biosciences (ARTL) Return on Capital Employed [ROCE] (2015 - 2025)

Updated

Artelo Biosciences (ARTL) reported Return on Capital Employed [ROCE] of -759.92% for Q1 2025, down 666.76 percentage points from -93.16% a year earlier and down 516.06 percentage points from the prior quarter.

Analysis

Artelo Biosciences (ARTL) Return on Capital Employed [ROCE] (2015 - 2025) Analysis & Trends

For FY2024, Artelo Biosciences posted Return on Capital Employed [ROCE] of -142.40%, down 78.09 percentage points from FY2023.

  • Return on Capital Employed [ROCE] has a five-year change of -9.68 percentage points (FY2019 to FY2024).
  • By year, Return on Capital Employed [ROCE] came in at -64.30% in FY2023 (-20.23 pp), -44.08% in FY2022 (+4.43 pp), -48.50% in FY2021 and -95.08% in FY2020 (+37.63 pp).
  • The Q1 2025 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] since Q2 2018.
  • Year over year, Return on Capital Employed [ROCE] has now declined in each of the last nine quarters, with an average year-over-year change of -135.58 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q3 2021 (a gain of 76.96 percentage points); the low point was Q1 2025 (a drop of 666.76 percentage points).
  • Per Business Quant data, the three quarters before Q1 2025 came in at -243.86% (Q4 2024), -135.57% (Q3 2024) and -130.42% (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Artelo Biosciences 73,320.32 -5.06 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -759.92%
Dec 31, 2024 -243.86%
Sep 30, 2024 -135.57%
Jun 30, 2024 -130.42%
Mar 31, 2024 -93.16%
Dec 31, 2023 -76.50%
Sep 30, 2023 -66.59%
Jun 30, 2023 -58.25%
Mar 31, 2023 -57.09%
Dec 31, 2022 -50.37%
Sep 30, 2022 -40.83%
Jun 30, 2022 -36.84%
Mar 31, 2022 -31.94%
Nov 30, 2021 -40.21%
May 31, 2021 -52.79%
Feb 28, 2021 -48.45%
Nov 30, 2020 -73.94%
Aug 31, 2020 -136.47%
May 31, 2020 -129.75%
Feb 29, 2020 -104.44%
API Access

Artelo Biosciences Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ARTL&period=max&api_key=YOUR_API_KEY